Stock MET.PRA METLIFE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials MetLife, Inc. Nyse

Equities

MET.PRA

US59156R5046

Life & Health Insurance

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-17 pm EDT 		5-day change 1st Jan Change
24.84 USD -0.12% Intraday chart for MetLife, Inc. +1.59% +7.77%
May. 10 Jones Lang LaSalle Arranges $735 Million Term Loan to Refinance Swan and Dolphin Resort MT
May. 10 Wells Fargo Adjusts Price Target on MetLife to $85 From $86, Keeps Overweight Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 46,874 42,253 52,564 56,782 48,949 52,780 - -
Enterprise Value (EV) 1 46,874 42,253 52,564 76,220 56,093 153,372 144,955 154,880
P/E ratio 8.41 x 8.27 x 8.55 x 24.9 x 36.5 x 9.55 x 8.08 x 7.41 x
Yield 3.41% 3.88% 3.04% 2.74% 3.12% 2.92% 3.01% 3.2%
Capitalization / Revenue 0.7 x 0.64 x 0.75 x 0.75 x 0.68 x 0.72 x 0.69 x 0.66 x
EV / Revenue 0.7 x 0.64 x 0.75 x 1.01 x 0.78 x 2.1 x 1.9 x 1.93 x
EV / EBITDA - - - - 6.18 x 17.8 x 18.3 x -
EV / FCF - - 4.17 x - - 31.9 x 20.8 x -
FCF Yield - - 24% - - 3.13% 4.81% -
Price to Book 0.74 x 0.6 x 0.81 x 2.43 x 1.84 x 1.97 x 1.78 x 1.61 x
Nbr of stocks (in thousands) 919,631 899,949 841,160 784,606 740,190 711,123 - -
Reference price 2 50.97 46.95 62.49 72.37 66.13 74.22 74.22 74.22
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 66,974 66,465 70,244 75,548 71,715 72,947 76,276 80,317
EBITDA 1 - - - - 9,080 8,607 7,941 -
EBIT 1 7,559 8,120 11,000 8,221 8,362 8,072 7,968 8,666
Operating Margin 11.29% 12.22% 15.66% 10.88% 11.66% 11.07% 10.45% 10.79%
Earnings before Tax (EBT) 1 6,795 6,927 8,126 2,859 2,162 7,953 8,509 8,986
Net income 1 5,721 5,191 6,353 2,354 1,380 5,576 6,259 6,653
Net margin 8.54% 7.81% 9.04% 3.12% 1.92% 7.64% 8.21% 8.28%
EPS 2 6.060 5.680 7.310 2.910 1.810 7.772 9.191 10.02
Free Cash Flow 1 - - 12,596 - - 4,807 6,974 -
FCF margin - - 17.93% - - 6.59% 9.14% -
FCF Conversion (EBITDA) - - - - - 55.85% 87.82% -
FCF Conversion (Net income) - - 198.27% - - 86.21% 111.42% -
Dividend per Share 2 1.740 1.820 1.900 1.980 2.060 2.166 2.236 2.375
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 20,211 17,724 18,298 23,690 15,836 16,126 18,634 15,866 18,718 17,016 18,174 18,551 18,963 18,409 18,665
EBITDA - - - - - - - - - - - - - - -
EBIT 1 2,353 2,500 2,357 1,576 1,788 1,857 2,221 2,288 1,996 2,095 2,296 2,402 2,475 - -
Operating Margin 11.64% 14.11% 12.88% 6.65% 11.29% 11.52% 11.92% 14.42% 10.66% 12.31% 12.63% 12.95% 13.05% - -
Earnings before Tax (EBT) 1 1,306 715 -2 419 1,727 257 430 534 941 1,045 1,989 2,220 2,240 - -
Net income 1 1,176 606 103 331 1,314 14 370 422 574 800 1,454 1,549 1,607 1,527 1,616
Net margin 5.82% 3.42% 0.56% 1.4% 8.3% 0.09% 1.99% 2.66% 3.07% 4.7% 8% 8.35% 8.47% 8.29% 8.66%
EPS 2 1.390 0.7300 0.1300 0.4100 1.660 0.0200 0.4800 0.5600 0.7700 1.100 2.044 2.188 2.277 2.172 2.405
Dividend per Share 2 0.4800 0.4800 0.5000 0.5000 0.5000 0.5000 0.5200 - 0.5200 0.5200 0.5420 0.5420 0.5420 0.5400 0.5600
Announcement Date 2/2/22 5/4/22 8/3/22 11/2/22 2/1/23 5/3/23 8/2/23 11/1/23 1/31/24 5/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 19,438 7,144 100,592 92,175 102,100
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - - - - 0.7868 x 11.69 x 11.61 x -
Free Cash Flow 1 - - 12,596 - - 4,807 6,974 -
ROE (net income / shareholders' equity) 13.1% 11.9% 16.6% 12.3% 13.6% 14.8% 15.2% 15.4%
ROA (Net income/ Total Assets) 0.8% 0.68% 0.82% 0.78% 0.82% 1.1% 1.1% 1.2%
Assets 1 713,965 767,899 777,411 302,765 168,684 506,905 568,984 554,409
Book Value Per Share 2 68.60 78.70 77.10 29.80 35.90 37.60 41.80 46.00
Cash Flow per Share - 12.70 14.50 16.30 - - - -
Capex 1 - - - - - 2,979 3,093 -
Capex / Sales - - - - - 4.08% 4.06% -
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/31/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for MetLife, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
74.22 USD
Average target price
82.41 USD
Spread / Average Target
+11.04%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Life & Health Insurance

1st Jan change Capi.
AXA Stock AXA
+14.24% 80.23B
AFLAC INCORPORATED Stock Aflac Incorporated
+7.12% 49.51B
MANULIFE FINANCIAL CORPORATION Stock Manulife Financial Corporation
+24.11% 47.43B
PRUDENTIAL FINANCIAL, INC. Stock Prudential Financial, Inc.
+16.97% 43.06B
GENERALI Stock Generali
+30.23% 41.91B
SUN LIFE FINANCIAL INC. Stock Sun Life Financial Inc.
+2.40% 29.93B
GREAT-WEST LIFECO INC. Stock Great-West Lifeco Inc.
-2.49% 29.2B
PRUDENTIAL PLC Stock Prudential plc
-7.66% 28.73B
CATHAY FINANCIAL HOLDING CO., LTD. Stock Cathay Financial Holding Co., Ltd.
+23.28% 25.73B
Other Life & Health Insurance
  1. Stock Market
  2. Equities
  3. MET Stock
  4. MET.PRA Stock
  5. Financials MetLife, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW